Legal Week - Latham & Watkins

Latham & Watkins Articles

Sullivan and Latham lead on Teva’s $40.5bn acquisition of Allergan Generics
2015-07-28 08:38 UTC by Frances Ivens, contributor

Teva Pharmaceutical's has purchased Allergan Generics for $40.5bn(£26bn) in a cash and stock deal expected to close next year